282 filings
Page 2 of 15
8-K
9bsf th96u5jd
7 Nov 22
RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
9:00am
8-K
6741moez3 o3
13 Sep 22
Regulation FD Disclosure
4:05pm
8-K
pbou29mp2jb36 ltgrq6
3 Aug 22
Payment Settlement Agreement and Release
4:05pm
8-K
47q6l
16 Jun 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:30am
8-K
wco51 c1qg
16 May 22
Entry into a Material Definitive Agreement
9:15am
8-K
u9w9xjctko9r svf
4 Apr 22
Entry into a Material Definitive Agreement
9:21am
8-K
l3t3z
28 Mar 22
Entry into a Material Definitive Agreement
4:05pm
8-K
abge4 awz
23 Mar 22
Regulation FD Disclosure
8:30am
8-K
lwou6za 1q73p0gw
7 Mar 22
Regulation FD Disclosure
8:15am
8-K
o9cih ipjrkgzpe
11 Feb 22
Departure of Directors or Certain Officers
5:13pm
8-K
te110c057
10 Jan 22
Departure of Directors or Certain Officers
8:30am
8-K
g93uuy
29 Dec 21
Note Purchase Agreement
4:05pm
8-K
mjp8yo
14 Dec 21
Entry into a Material Definitive Agreement
4:12pm
8-K
qlsd1emmd i1d
14 Dec 21
Regulation FD Disclosure
8:43am
8-K
k8sth2
23 Nov 21
Entry into a Material Definitive Agreement
4:05pm
8-K
po8y9dqoud
22 Nov 21
RespireRx Pharmaceuticals Inc. Announces CEO’s OTC Venture Market Podcast
9:04am
8-K
o1g0h
4 Nov 21
RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
9:20am
8-K
i99hzzseci05rngay
12 Oct 21
Securities Purchase Agreement
4:15pm
8-K
h8ysc5
28 Sep 21
Amendment No. 2 to Employment Agreement
5:11pm
8-K
d9xf8j95zthfg 9gq
20 Sep 21
Entry into a Material Definitive Agreement
9:15am